Rallybio
RLYB
62 hedge funds and large institutions have $55.9M invested in Rallybio in 2024 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 15 increasing their positions, 17 reducing their positions, and 5 closing their positions.
160% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 5
15% more funds holding
Funds holding: 54 → 62 (+8)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0.55% less ownership
Funds ownership: 10.54% → 9.98% (-0.55%)
12% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 17
27% less capital invested
Capital invested by funds: $76.1M → $55.9M (-$20.3M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$850K |
| 2 |
Millennium Management
New York
|
+$281K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$141K |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$54.5K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$39.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
-$4.23M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$446K |
| 3 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$440K |
| 4 |
Morgan Stanley
New York
|
-$212K |
| 5 |
BlackRock
New York
|
-$139K |
RLYB Hedge Fund Activity: Q1 2024 in Review
62 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Rallybio (RLYB) for Q1 2024, worth a combined $55.9M — down 27% from $76.1M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new RLYB positions and 5 closed out — a net gain of 8 holders — while 15 added to existing stakes and 17 trimmed.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $850K. The largest seller was Novo Holdings A/S, exiting entirely with an estimated $4.23M sold.
- 62 institutional investors held Rallybio (RLYB) as of Q1 2024, up from 54 in Q4 2023.
- Funds reported $55.9M of Rallybio stock for Q1 2024, down 27% quarter-over-quarter.
- 13 funds opened new Rallybio positions in Q1 2024 and 5 closed out, a net change of +8 holders.
- The largest Rallybio buyer in Q1 2024 was Renaissance Technologies, an estimated $850K added.
- The largest Rallybio seller in Q1 2024 was Novo Holdings A/S, an estimated $4.23M sold.
Based on aggregated 13F filings for Q1 2024.